Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.

UroGen Pharma (URGN) announced that adult patients living with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer now have improved access to an important therapy, as the ...

Functional packaging materials are increasingly designed to actively protect drug products, integrating moisture and impurity ...

Oasis urges Kobayashi Pharma shareholders to vote FOR a highly qualified, independent statutory auditor candidate*Oasis urges Kobayashi Pharma shareholders to vote FOR Oasis’s proposals to change the ...

India has rolled out a new QR code-based verification system to help consumers check the authenticity of medicines and ...

Next week, Greenfield City Council will vote on whether to grant a 15-year tax abatement on personal property for West ...

Domino Printing Sciences (Domino) is participating at Pharmapack Europe 2026, where the business will contribute to the ...

Torrent Pharmaceuticals Limited has completed the acquisition of a controlling stake in J.B. Chemicals & Pharmaceuticals Limited, officially becoming its promoter with effect ...

Industry reports the Saudi pharmaceutical CDMO market is expected to increase from USD $1.62 billion in 2024 to USD $2.24 billion by 2030 at a compound annual growth rate (CAGR) of 5.45%, reflecting ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on February 5, 2026, at 4:30 p.m. ET to discuss its financial results for the fiscal 2026 ...

Explore how modern workflows are changing compliance for biotech and pharma IT teams by improving traceability, automation, ...

Indonesia’s Food and Drug Authority (BPOM) has formalised cooperation with Singapore’s Health Sciences Authority (HSA) in the ...